Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Dermatologic 3Gynecologic 2Tumor-Agnostic 1Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1Classical hematology 1CNS 1Breast 1

Conditions

Vaginal Diseases 1Uterine Cervical Neoplasms 1Papillomavirus Infections 1Cervical Cancer Screening 1

Interventions

Paclitaxel 581Carboplatin 527Cisplatin 355Bevacizumab 256pembrolizumab 226Gemcitabine 157liposomal doxorubicin 132Topotecan 131olaparib 129Cyclophosphamide 126Radiotherapy 118Taxes 114Docetaxel 95Brachytherapy 94Drug Therapy 90niraparib 88Doxorubicin 86Surveys and Questionnaires 85Magnetic Resonance Spectroscopy 80Blood Specimen Collection 73Nivolumab 71Specimen Handling 70Hyperthermic Intraperitoneal Chemotherapy 64Biopsy 63fludarabine 56Filgrastim 53Letrozole 50Oxaliplatin 49durvalumab 47Immunoglobulin G 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Vaccination × Gynecologic × Clear all
NCT07113379 2025-08-08

REVIVE

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting
200 enrolled
Gynecologic

Cervical Cancer Screening

NCT05938192 2025-05-09

Multimodality Treatments of HPV-related Lesions of the Female Genital Tract

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Recruiting
200 enrolled
Gynecologic

Uterine Cervical Neoplasms, Vaginal Diseases, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡